Cathy Kao

TLC BioSciences

At TLC, we are dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy. We focus on creating new therapies in the areas of pain management, oncology, ophthalmology and infectious diseases. Effective drug development is a challenging and complex effort that requires the coordinated talents of many skilled individuals working as a team. If you believe in the potential for new medicines to improve quality of life and bring hope to those in need, we invite you to join us. We welcome applications from all over the globe.